Sociedade Brasileira de Hematologia e Hemoterapia
Sociedade Brasileira de Hematologia e Hemoterapia
 

  NOVOS SÓCIOS

Seja sócio da SBHH!
Faça o cadastro!
Faça seu cadastro!

  NAVEGADOR SBHH

Busca de Artigos Científicos
Controle de Qualidade Externo em Imuno-hematologia
Controle de Qualidade em Hemoterapia
HEMO 2007
Datas Comemorativas da Área da Saúde
Ética Médica
Legislação
Links
Publicações
Quem é Quem nos Hemocentros
Sala de Imprensa

SBHH Responde

Doação de Sangue
Onde, como e quem pode?

BRITISH JOURNAL OF HAEMATOLOGY 137 (4) - Maio 2007 (2ª quinzena)

Images in Haematology

Purpura fulminans in paroxysmal nocturnal haemoglobinuria
Simon G. Watt, Sandra Winhoven, Charles R. M. Hay, Guy S. Lucas
p. 271-271

Aplastic anaemia as an autoimmune complication of thymoma
Murat O. Arcasoy, Jon P. Gockerman
p. 272-272

Reviews

Predicting the outcome in non-Hodgkin lymphoma with molecular markers
Yok-Lam Kwong
p. 273-287

The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target
Jan A. Burger, Andrea Bürkle
p. 288-296

Haematological Malignancy

Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia
Jörg Westermann, Joachim Kopp, Antje van Lessen, Ann-Christine Hecker, Gökben Baskaynak, Philipp le Coutre, Konstanze Döhner, Hartmut Döhner, Bernd Dörken, Antonio Pezzutto
p. 297-306

The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics
Wouter Korver, Shweta Singh, Shouchun Liu, Xiaoxian Zhao, Shirlee Yonkovich, Allison Sweeney, Kristin Anton, Woodrow E. Lomas III, Rachel Greenwood, Ashley Smith, Denise Hoang Tran, Pauline Shinkawa, Mark Jimenez, Patricia Yeung, Gerard Aguilar, Servando Palencia, Paolo Vatta, Matthew Mueller, Xiaoming Zhan, Elizabeth M. Newton, Yi Liu, Jingsong Zhao, Peter Emtage, Michael D. Levy, Eric D. Hsi, Walter D. Funk, Arie Abo
p. 307-318

Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia
Nicholas G. Gottardo, Katrin Hoffmann, Alex H. Beesley, Joseph R. Freitas, Martin J. Firth, Kanchana U. Perera, Nicolas H. de Klerk, David L. Baker, Ursula R. Kees
p. 319-328

Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas
Je-Jung Lee, Dong Hwan Kim, Nan Young Lee, Sang Kyun Sohn, Jong Gwang Kim, Hyeoung-Joon Kim, Young Rok Do, Yeon Hee Park
p. 329-336

Loss-of-function JAK3 mutations in TMD and AMKL of Down syndrome
Serena De Vita, Claire Mulligan, Suzanne McElwaine, Franca Dagna-Bricarelli, Monica Spinelli, Giuseppe Basso, Dean Nizetic, Jürgen Groet
p. 337-341

Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis
Andreas Lietz, Martin Janz, Mikael Sigvardsson, Franziska Jundt, Bernd Dörken, Stephan Mathas
p. 342-348

Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
Mitsufumi Nishio, Katsuya Fujimoto, Satoshi Yamamoto, Tomoyuki Endo, Toshiya Sakai, Masato Obara, Kohki Kumano, Keisuke Yamaguchi, Yukari Takeda, Hideki Goto, Norihiro Sato, Kazuki Koizumi, Masaya Mukai,Takao Koike
p. 349-354

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia
Issa F. Khouri, Rima M. Saliba, Joan Admirand, Susan O'Brien, Ming-S. Lee, Martin Korbling, Barry I. Samuels, Sergio Giralt, de Marcos Lima, Michael J. Keating, Richard E. Champlin, Carlos Bueso-Ramos
p. 355-363

The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma
Sverker Hasselblom, Margret Sigurdadottir, Ulrika Hansson, Herman Nilsson-Ehle, Börje Ridell, Per-Ola Andersson
p. 364-373

Correspondence
Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy
Karthik Ramasamy, Janet Hayden, ZiYi Lim, Ghulam J. Mufti, Aloysius Y. L. Ho
p. 374-375

GATA1 mutational analysis in chronic myeloid leukaemia
Christina Halsey, Chris Fisher, Gordon Strathdee, Brenda Gibson, Tessa Holyoake, Paresh Vyas, Gerry Graham
p. 375-376

Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
Chi-Chiu So, Thomas SK, Wan Sze-Fai ,Yip Shiu-Kwan ,Ma Clarence, CC Lam, Li-Chong Chan
p. 377-377

Haematopoietic cell lineage distribution of MPLW515L/K mutations in patients with idiopathic myelofibrosis
Wen-Yang Hu, Yan Zhao, Takefumi Ishii, Selcuk Sozer, Jun Shi, Wei Zhang, Edward Bruno, Ronald Hoffman, Mingjiang Xu
p. 378-379

Loss of H19 imprinting in adult T-cell leukaemia/lymphoma
Seisho Takeuchi Wolf-Karsten Hofmann Kunihiro Tsukasaki Naoko Takeuchi Takayuki Ikezoe Masahide Matsushita Yoshio Uehara H. Phillip Koeffler
p. 380-381

Hybrid eosinophilic-basophilic acute myeloid leukaemia diagnosed by electron microscopy
Lev Shvidel, Erica Sigler, Mordechai Shtalrid, Alain Berrebi, Peretz Resnitzky
p. 381-383

  Sociedade Brasileira de Hematologia e Hemoterapia
  Rua da Assembléia, nº 10 Grupo 1704 - Centro - Rio de Janeiro - RJ - Brasil - CEP 20011-901
  Tel/Fax: +55 (21) 3511-1101